Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
CIDP
Central nervous system
Evoked potentials
Neurography
Sensory conduction velocity
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
01
09
2019
accepted:
16
03
2020
pubmed:
27
3
2020
medline:
15
5
2021
entrez:
27
3
2020
Statut:
ppublish
Résumé
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nervous system, sometimes including the central nervous system. The aim of the study was the assessment of the prevalence of central sensory impairment and its reliance on peripheral nerve damage in patients with CIDP. Multimodal (visual-VEP, brainstem auditory-BAEP, somatosensory-SEP) evoked potentials (EPs) were studied in 24 patients diagnosed with CIDP. The results were compared with neurographic parameters of sensory responses. The control group consisted of 35 healthy volunteers selected with respect to age and sex. Mean latency of most components of EP were considerably prolonged in patients compared with the control group. There were no correlations between the P100 VEP latency and the peripheral sensory parameters. Statistically significant negative correlations were obtained between BAEP and SEP responses and the amplitude and sensory conduction velocity of peripheral nerves. The inter-latencies were also longer. The authors indicated to the possibility of central sensory involvement in patients with CIDP, especially based on the prolonged inter-latency of BAEPs with simultaneously confirmed root affection. The severity of central damage correlates with the degree of peripheral nerve impairment.
Identifiants
pubmed: 32212008
doi: 10.1007/s10072-020-04351-3
pii: 10.1007/s10072-020-04351-3
pmc: PMC7419376
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2495-2501Références
Austin JH (1958) Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81:157–192
doi: 10.1093/brain/81.2.157
Dyck PJ, O’Brien PC, Oviatt KF, Dinapoli RP, Daube RP, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11:136–141
doi: 10.1002/ana.410110205
Sanvito L, Makowska A, Mahdi-Rogers M, Hadden RDM, Peakman M, Gregson N, Nemni R, Hughes RAC (2009) Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 80:333–338
doi: 10.1136/jnnp.2008.159798
Fan C, Jin H, Hao H, Gao F, Sun Y, Lu Y, Liu Y, Lv P, Cui W, Teng Y, Huang Y (2017) Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients. Muscle Nerve 55:470–475
doi: 10.1002/mus.25266
PeiLim J, Devaux J, Yuki N (2014) Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmun Rev 13:1070–1078
doi: 10.1016/j.autrev.2014.08.005
Melody R, Stephen JR (2018) Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Am J Manag Care 24(17suppl):S371–S379
Hu B, Zhou Y, Lu X, Xiong Q, Liu Q, Qi X, Ding W (2018) Chronic inflammatory demyelinating polyradiculoneuropathy: a case report. Medicine (Baltimore) 97:e12469. https://doi.org/10.1097/MD.0000000000012469
doi: 10.1097/MD.0000000000012469
Mendel JR, Kolkin S, Kissel JT, Weiss KL, Chakeres DW, Rammohan Kottil W (1987) Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculopathy. Neurol 37:1291–1294
doi: 10.1212/WNL.37.8.1291
Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, Koski CL, Léger JM, Nobile-Orazio E, Pollard J, Sommer C, van Doorn PA, van Schaik IN (2010) Peripheral Nerve Society: European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17:356–363
doi: 10.1111/j.1468-1331.2009.02930.x
Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakini R, Mauguiere F, Rossini PM, Treede RD, Garcia-Larrea L (2008) Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 119:1705–1719
doi: 10.1016/j.clinph.2008.03.016
Holder GE, Celesia GG, Miyake Y, Tobimatsu S, Weleber RG (2010) International Federation of Clinical Neurophysiology:.International Federation of Clinical Neurophysiology: recommendations for visual system testing. Clin Neurophysiol 121:1393–1409
doi: 10.1016/j.clinph.2010.04.010
Lee E-M, Seok HY, Park KD, Seo D-W (2018) Evoked potentials: basic requirements and guidelines for writing reports. Ann Clin Neurophysiol 20:18–25
doi: 10.14253/acn.2018.20.1.18
Oh SJ (2003) Clinical electromyography: nerve conduction studies. Lippincott, Williams and Wilkins, Philadelphia, pp 1705–1719
Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC (1993) Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 56:1178–1183
doi: 10.1136/jnnp.56.11.1178
Del Sordo E, Casali S, Ginanneschil F, Insana L, Capoccitti G, Cardinali C, Battista D, Borgheresi A, Cincotta M, Borsini W, Giannini F (2015) CANOMAD: clinical and neurophysiological findings in two cases. Clin Neurophysiol 126:e21–e22
doi: 10.1016/j.clinph.2014.10.112
Sanvito L, Rajabally YA (2011) Optic neuropathy associated with CANOMAD: description of 2 cases. Muscle Nerve 44:451–455
doi: 10.1002/mus.22157
Knopp M, Leese RJ, Martin Lamb D, Rajabally YA (2014) Optic and auditory pathway dysfunction in demyelinating neuropathies. Acta Neurol Scand 130:53–57
doi: 10.1111/ane.12226
Cabrera-Lima AV, Gutiérrez J, Martínez E, Estrada R (1999) Electrophysiological characteristics of inflammatory demyelinating chronic polyneuropathy. Rev Neurol 28:353–357
pubmed: 10714311
Ormerod IE, Waddy HM, Kermode AG, Murray NM, Thomas PK (1990) Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 53:789–793
doi: 10.1136/jnnp.53.9.789
Graf J, Jansen L, Ingwersen J, Ringelstein M, Harmel J, Rybak J, Kolbe R, Rhöse L, Gemerzki L, Lee JI, Klistorner A, Guthoff R, Hartung HP, Aktas O, Albrecht P (2018) Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol 5:952–961
doi: 10.1002/acn3.593
Stojkovic T, de Seze J, Hurtevent JF, Arndt C, Beaume A, Hache JC, Vermersch P (2000) Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 111:2285–2291
doi: 10.1016/S1388-2457(00)00478-8
Sun RD, Fu B, Jiang J (2017) Role of short-latency somatosensory evoked potentials in the diagnosis of chronić inflammatory demyelinating polyneuropathy. Zhongguo Dang Dai Er Ke Za Zhi 19:545–548
pubmed: 28506346
Salhi H, Corcia P, Remer S, Praline J (2014) Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Neurophysiol 31:241–245
doi: 10.1097/WNP.0000000000000050
Koutlidis RM, Ayrignac X, Pradat P-F, Le Forestier N, Leger J-M, Salachas F, Maisonobe T, Fournier E, Viala K (2014) Segmental somatosensory-evoked potentials as a diagnostic tool in chronic inflammatory demyelinating polyneuropathies, and other sensory neuropathies. Neurophysiol Clin 44:267–280
doi: 10.1016/j.neucli.2014.08.006
Hanajima R, Terao Y, Yugeta A, Hamada M, Shirota Y, Ohminami S, Nakatani-Enomoto S, Tsuji S, Ugawa Y (2010) Prominent cauda equina involvement in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 290:112–114
doi: 10.1016/j.jns.2009.10.014
Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, Soper JR (1999) Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122:1383–1390
doi: 10.1093/brain/122.7.1383
Schady W, Goulding PJ, Lecky BR, King RH, Smith CM (1996) Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 61:636–640
doi: 10.1136/jnnp.61.6.636